Analyst
Stifel
Equibles does not estimate personal net worth.
Annie is recorded as Analyst at Stifel. Annie has spoken on 3 earnings calls and 3 other investor events across 2 companies, most recently for Lemaitre Vascular Inc on August 4, 2026. Those appearances were for Lemaitre Vascular Inc (LMAT) and Pulmonx Corp (LUNG). The companies whose calls Annie spoke on are classified in the Healthcare sector.
“And maybe just to follow up on the RFA supply constraints, maybe just generally about the longer-term opportunity outside the U.S. I'm curious if you have any plans to build out tissue processing OUS and what that might entail in terms of the timing, investment, and regulatory work there.”
“So, my first one is on the first quarter OUS autograph performance. I think I heard you call out 2.1 million in sales this quarter, which would sort of imply this annual run rate that's a bit below your 10 million target for the full year.”
“So, my first one is on the first quarter OUS autograph performance. I think I heard you call out 2.1 million in sales this quarter, which would sort of imply this annual run rate that's a bit below your 10 million target for the full year.”
“So, my first one is on the first quarter OUS autograph performance. I think I heard you call out 2.1 million in sales this quarter, which would sort of imply this annual run rate that's a bit below your 10 million target for the full year.”
“So my first one is on the first quarter OUS autographed performance. I think I heard you call out $2.1 million in sales this quarter, which would sort of imply this annual run rate that's a bit below your $10 million target for the full year.”
Stifel
Analyst
Transcript header (unverified)
Medical Instruments & Supplies · Healthcare
LUNG
Medical Devices · Healthcare
